Enlivex moves 1-for-13 to 1-for-16 vote for Enlivex stock
Published on 10/13/2026 at 04:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Enlivex moved its proposed reverse split vote to October 16, 2026.
- The proposed first split ranges from 1-for-13 to 1-for-16, with further authority up to 1-for-1,000.
- Enlivex reported USD 1.949 billion net income for the first half of 2026, alongside a USD 15.828 million operating loss.
- The last Lang & Schwarz quote was EUR 0.23 on October 12, 2026.
Enlivex stock is heading toward a shareholder vote on a proposed reverse split ranging from 1-for-13 to 1-for-16. According to StockTitan on October 2, 2026, Enlivex moved the extraordinary meeting to October 16, 2026, when shareholders will consider the split and additional authority covering 1-for-2 to 1-for-1,000.
Chronology sets the timeline
On July 9, 2026, Enlivex made a 1-for-15 reverse split effective, according to the Enlivex investor-relations page. On September 22, 2026, the company terminated a previously announced USD 400 million private placement payable in RAIN tokens, according to Panabee. On October 2, 2026, the amended filing set the next vote for October 16 and kept the first proposed ratio at 1-for-13 to 1-for-16.
What does the vote change?
The proposal is designed to lift the share price above Nasdaq's USD 1.00 minimum bid requirement. The filing says Enlivex had closed below that threshold each trading day since September 10, 2026, and that 30 consecutive sub-USD 1.00 trading days through October 21, 2026, could lead to a Nasdaq staff delisting determination.
The arithmetic of a reverse split does not by itself change a holder's ownership percentage. The filing states that authorized and outstanding shares would be reduced in line with the approved ratio, while warrants, options and restricted share units would be adjusted under their terms. It also says fractional shares would be rounded up to the nearest whole share.
Financial results add a second risk
For the six months ended June 30, 2026, Enlivex reported USD 1.949 billion of net income, compared with a USD 5.320 million net loss in the comparable prior-year period. The result included USD 609.763 million of income from digital assets and a USD 1.944 billion gain from changes in the fair value of the RAIN option, according to StockTitan.
The same filing reported a USD 15.828 million operating loss and USD 5.518 million of cash and cash equivalents for June 30, 2026. That contrast matters: accounting gains from digital assets dominated reported net income, while the operating business remained loss-making.
Upcoming dates for Enlivex
The extraordinary shareholder meeting is scheduled for October 16, 2026, at 10:00 a.m. Israel time, according to StockTitan. Earnings Today lists November 13, 2026, as the scheduled reporting date.
Last euro quote and listing data
Enlivex was last at EUR 0.23 at Lang & Schwarz on October 12, 2026 at 10:57 p.m. CEST. The structured quote data showed a USD 4.3 million market capitalization and a USD 0.22 to USD 27.15 52-week range as of October 12, 2026. The further course of trading is shown by the continuously updated real-time quote of Enlivex stock.
Enlivex stock facts
- Company: Enlivex Ltd.
- ISIN: IL0011319527
- WKN: A119KH
- Ticker: ENLV
- Primary exchange: Nasdaq
- Last price Lang & Schwarz (as of October 12, 2026, 10:57 p.m. CEST): EUR 0.23
- Market capitalization: USD 4.3 million (as of October 12, 2026)
- 52-week range: USD 0.22-27.15 (as of October 12, 2026)
- Sector / Industry: Healthcare / Biotechnology
- Next earnings date: November 13, 2026
Market context: Market report Nasdaq Composite.
